HbA1c Elution Buffer A, when used in conjunction with GSH-60 Automatic HPLC HbA1c Analyzer, is intended for in vitro diagnostic use for the quantitative determination of Hemoglobin A1c (HbA1c) in human whole blood.
2. Test Principle
High Performance Liquid Chromatography (HPLC) is applied. Based on the charge differences, this method separates HbF, HbA1c and total HbA1 by using the cation exchange column and three types of elution buffer with different salt concentrations. The percentage of HbA1c peak in relation to the total area is calculated as the HbA1c concentration (%).
Cat No.
Description
Pack Size
Unit
1 Reagent Kit (350 Tests)
GH1800
HbA1c Elution Buffer A
800 mL
1
GH2400
HbA1c Elution Buffer B
400 mL
1
GH3400
HbA1c Elution Buffer C
400 mL
1
Performance
Excellent precision: CV≤1.5%
Broader test range: 2.8%~18.4%
Report multiple glycation components to provide more comprehensive clinical reference
Easy Maintenance
Automated daily maintenance
Power-saving auto Stand-by function
Utilize 4~12 Mpa high pressure pump which offers steady output and minimizes pipe blockage
High Efficiency
Up to 60 tests per hour. STAT position supported.
Direct whole blood testing
Cap piercing and no sample pre-treatment
110 sample positions with automatic loading function.
Automatic identification of sample tube type.
Userfriendly 20° flippable touch screen
Prevention and monitoring of chronic
complications of diabetes mellitus
Differentiation
of stress hyperglycemia
from diabetes mellitus
Diagnosis of neonatal and gestational diabetes mellitus
Early screening and diagnosis of diabetes mellitus
Evaluation of the effectiveness of blood glucose control programs
The American Diabetes Association (ADA) recommends
HbA1c Recommended Testing Frequency:
At least twice a year in patients with stable and satisfactorily controlled blood glucose
For those with unsatisfactory blood glucose control and need to adjust their regimen, testing should be done once every 3 months or so
For pregnant women with diabetes mellitus treated with insulin, a test once every 2 months is recommended.
For women with diabetes who are planning to become pregnant, glycosylated hemoglobin should be measured once a month at the beginning;After the blood sugar control is satisfactory, the test can be changed to once every 6-8 weeks until conception.
*Product images are for illustrative purposes only and may differ from the actual product. Goldsite Diagnostics Inc. reserves the right to change the packaging design at anytime.
Performance
Easy Maintenance
High Efficiency
